IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Clinical trial NCT07508761 · RECRUITING
Trial details
- NCT number
- NCT07508761
- Sponsor
- Nanjing Immunophage Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2028-12-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.